Abstract:The placenta is responsible for delivering nutrients such as glucose to the fetus to support its growth and development, which is especially important during late gestation when fetal growth is most rapid. The ability of the placenta to efficiently provide nutrients is dependent on its vascular development and the abundance of nutrient transporters at the maternal fetal interface. Maternal choline supplementation (MCS) was shown to improve placental vasculature, but it is still unknown if MCS affects placental transporter abundance and fetal nutrient delivery. To test the hypothesis that MCS beneficially modulates placental glucose supply, pregnant mice were fed a diet containing 1, 2 or 4 times the recommended choline level. The placentas were collected at gestational day (E) 15.5 and 18.5 for evaluating the expression of key glucose transporters and enzymes involved in glycogen metabolism as well as the glycogen concentration. Data were analyzed using a mixed linear model. At E15.5, MCS reduced the membrane protein abundance of Glut1 transporter as well as the mRNA expression of the glycogen synthesizing enzyme Gys1 (p<0.05). The mRNA expression of the glycogen catabolic enzyme Pygm in the female placentas also tended to increase (p=0.08). Consistent with these findings, histological staining of placental glycogen tended to be lower (p=0.08). At E18.5, MCS had no effect on Glut1 transporter expression in either male or female placentas. However, MCS increased the membrane protein abundance of Glut3 transporter and the mRNA abundance of Gys1 in the female placentas (p<0.05). These changes resulted in a 2‐fold increase in glycogen concentration in the female placentas, as shown by histological staining and biochemical measurement (p<0.05). No such changes were seen in the male placentas at this time point. Overall, these data indicate that MCS modulates placental glucose transporter expression and glycogen metabolism in a manner highly dependent on fetal sex. We suggest that these choline‐mediated changes in placental glucose metabolism differentially influence glucose delivery to the fetus, with potential consequences on offspring development and disease risk in later life.Support or Funding InformationUSDA and Egg Nutrition Center

Maternal Choline Supplementation Modulates Maternal and Fetal Choline Metabolism and Downregulates Inflammatory Gene Expression in a Mouse Model of Placental Insufficiency

Maternal Choline Supplementation Modulates Placental Markers of Inflammation, Angiogenesis, and Apoptosis in a Mouse Model of Placental Insufficiency

Maternal Choline Supplementation Modulates Placental Nutrient Transport and Metabolism in Late Gestation of Mouse Pregnancy.

Maternal Choline Supplementation During Murine Pregnancy Modulates Placental Markers of Inflammation, Apoptosis and Vascularization in a Fetal Sex-Dependent Manner.

Maternal Choline Supplementation During Normal Murine Pregnancy Alters the Placental Epigenome: Results of an Exploratory Study.

A Genome‐Wide Analysis of Placental Epigenetic Markers in Response to Maternal Choline Supplementation

Maternal Choline Supplementation Influences Placental Glucose Uptake and Metabolism in a Manner Dependent on Fetal Sex

Choline Affects Placental Vascular Function and Development in a Dose Response Manner

A Higher Maternal Choline Intake Favorably Alters Placental Gene Expression of Biological Pathways Related to Disease Risk

Choline Prevents Fetal Overgrowth and Normalizes Placental Fatty Acid and Glucose Metabolism in a Mouse Model of Maternal Obesity.

A Higher Maternal Choline Intake among Third‐trimester Pregnant Women Lowers Placental and Circulating Concentrations of the Antiangiogenic Factor Fms‐like Tyrosine Kinase‐1 (Sflt1)

Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes

Maternal Choline and Betaine Supplementation Modifies the Placental Response to Hyperglycemia in Mice and Human Trophoblasts

Choline Inadequacy Impairs Trophoblast Function and Vascularization in Cultured Human Placental Trophoblasts

Maternal Choline Supplementation Alters Vitamin B-12 Status in Human and Murine Pregnancy

Choline Supplementation Normalizes Fetal Adiposity and Reduces Lipogenic Gene Expression in a Mouse Model of Maternal Obesity

Maternal Choline Intake Modulates Maternal and Fetal Biomarkers of Choline Metabolism in Humans

Choline Modulates Soluble‐Endoglin (seng) and Vascular Endothelial Growth Factor (VEGF) in Cultured Human Placental Trophoblasts

Fetal Stress Markers Are Lowered by Maternal Choline Intakes Exceeding Recommendations

Choline And Betaine Supplementation Affects Biomarkers In Mice With Gestational Diabetes

Maternal Choline Intake Alters the Epigenetic State of Fetal Cortisol‐regulating Genes in Humans